Literature DB >> 29626470

Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1.

Liangzhi Gong1, Qiyuan Bao1, Chuanzhen Hu1, Jun Wang2, Qi Zhou2, Li Wei2, Lei Tong3, Weibin Zhang4, Yuhui Shen5.   

Abstract

Exosomal microRNAs(miRNAs) transfer from tumor to stromal cells is reportedly associated with cancer progression and metastasis in various epithelial cancers. However, the role of exosomal miRNA in the metastasis of osteosarcoma(OS) -the most common bone malignancy-still largely remains unknown. In this study, we purified exosomes with a median size close to 100 nm from cell culture media as well as patient serum, and proved that exosomes derived from the metastatic, but not the non-metastatic OS cells increase the migration and invasion of non-malignant fibroblast cells (hFOB1.19) in vitro. Furthermore, the differential miRNA cargo between metastatic and non-metastatic OS is identified by small RNA sequencing and RT-PCR validation, we found a highly expression of exosomal, but not cellular miR-675 level in the metastatic OS cell-lines compared with non-metastatic counterparts. Meanwhile, we also found that exosomal miR-675 could down-regulate CALN1 expression in recipient cell, which may influence the invasion and migration of hFOB1.19. Finally, the up regulation serum exosomal miR-675 and down regulation of CALN1 in tumor specimen was also found to be associated with the metastatic phenotype in OS patients. Our findings indicate that the exosomal miR-675 is a gene associated with OS and serum exosomal miR-675 expression may serve as a novel biomarker for the metastasis of OS.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CALN1; Exosome; Migration; Osteosarcoma; miR-675

Mesh:

Substances:

Year:  2018        PMID: 29626470     DOI: 10.1016/j.bbrc.2018.04.016

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  Exosomes in osteosarcoma research and preclinical practice.

Authors:  Xiao-Bo Zhang; Rui-Hao Zhang; Xin Su; Jin Qi; Yi-Cun Hu; Jin-Tao Shi; Kai Zhang; Ke-Ping Wang; Hai-Yu Zhou
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 2.  The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancer.

Authors:  Clément Lecerf; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Cell Mol Life Sci       Date:  2019-07-23       Impact factor: 9.261

3.  Identification of potential biomarkers and candidate small molecule drugs in glioblastoma.

Authors:  Wei-Cheng Lu; Hui Xie; Ce Yuan; Jin-Jiang Li; Zhao-Yang Li; An-Hua Wu
Journal:  Cancer Cell Int       Date:  2020-08-28       Impact factor: 5.722

Review 4.  Emerging Function and Clinical Values of Exosomal MicroRNAs in Cancer.

Authors:  Man Wang; Fei Yu; Han Ding; Yu Wang; Peifeng Li; Kun Wang
Journal:  Mol Ther Nucleic Acids       Date:  2019-05-15

5.  Mesenchymal stem cell-derived extracellular vesicles may promote breast cancer cell dormancy.

Authors:  Jake Casson; Owen G Davies; Carol-Anne Smith; Matthew J Dalby; Catherine C Berry
Journal:  J Tissue Eng       Date:  2018-12-25       Impact factor: 7.813

Review 6.  Exosomal MiRNAs in Pediatric Cancers.

Authors:  Angela Galardi; Marta Colletti; Virginia Di Paolo; Patrizia Vitullo; Loretta Antonetti; Ida Russo; Angela Di Giannatale
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

7.  MiR-19a Promotes Migration And Invasion By Targeting RHOB In Osteosarcoma.

Authors:  Ruidong Liu; Liefeng Shen; Niyan Qu; Xia Zhao; Jialiang Wang; Jun Geng
Journal:  Onco Targets Ther       Date:  2019-09-23       Impact factor: 4.147

8.  Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions.

Authors:  Kerri Wolf-Dennen; Nancy Gordon; Eugenie S Kleinerman
Journal:  Oncoimmunology       Date:  2020-04-12       Impact factor: 8.110

Review 9.  The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance.

Authors:  Cristina P R Xavier; Hugo R Caires; Mélanie A G Barbosa; Rui Bergantim; José E Guimarães; M Helena Vasconcelos
Journal:  Cells       Date:  2020-05-06       Impact factor: 6.600

10.  Exosome-transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma.

Authors:  Qiming Li; Xuedi Wang; Nian Jiang; Xianbiao Xie; Ni Liu; JunFeng Liu; Jingnan Shen; Tingsheng Peng
Journal:  Cancer Med       Date:  2020-07-16       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.